Should You Investigate Progyny, Inc. (NASDAQ:PGNY) At US$22.90?
Progyny, Inc. Announces Details for Its First Quarter 2025 Results Report
Returns Are Gaining Momentum At Progyny (NASDAQ:PGNY)
Progyny Names Melissa Cummings COO
Progyny Appoints First COO and CPO to Enhance Women's Health and Family Building Solutions
Press Release: Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer
Progyny to Host Events Honoring Individuals, Families and Infertility Throughout National Infertility Awareness Week and Canadian Fertility Awareness Week
Press Release: The Broken Brown Egg and Progyny Announce the 2025 Awareness, Hope, and Activism Grant(TM) to Support BIPOC Individuals and Couples in Family Building
Bullish Progyny Insiders Loaded Up On US$5.24m Of Stock
Analyst Expectations For Progyny's Future
BTIG Upgrades Progyny(PGNY.US) to Buy Rating, Announces Target Price $28
Progyny Expands Maternal Health Support With Addition of Doula Services
BTIG Upgrades Progyny to Buy From Neutral, Price Target Is $28
BTIG Upgrades Progyny to Buy on Improving Demand
The Past Three Years for Progyny (NASDAQ:PGNY) Investors Has Not Been Profitable
James Hardie Industries, MINISO Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Progyny's (NASDAQ:PGNY) Earnings Trajectory Could Turn Positive as the Stock Ascends 8.4% This Past Week
Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup
Progyny Expands Family Building Solutions With New Parent and Child Well-being Offering
Truist Financial Maintains Progyny(PGNY.US) With Hold Rating